News

Epigenica Secures $2.2 Million to Propel Innovative Solutions

Epigenica Secures $2.2 Million to Propel Innovative Solutions

Epigenica Closes $2.2 Million Investment Round to Scale Cutting-Edge Epigenetic Solutions

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market

In a significant step towards advancing its pioneering epigenetic solutions, Epigenica AB has closed a $2.2 million investment round aimed at fostering growth and entering key markets. This funding round attracted the support of notable investors including Voima Ventures, Navigare Ventures, Leksell Social Ventures, and Almi Invest.

As biological research evolves, the integration of powerful new tools has allowed for enhanced data generation from RNA, proteins, and metabolites. These developments have been pivotal, giving rise to multi-omics approaches that adopt a more holistic view of biological systems. In this intricate landscape, epigenetics emerges as a crucial factor, shedding light on how biological processes are organized and regulated. Epigenica’s proprietary EpiFinder platform stands out by enabling the simultaneous analysis of diverse epigenetic markers across numerous samples while maintaining high resolution and efficiency.

Stina Wallmark, Investment Director at Voima Ventures, expressed enthusiasm regarding the potential of epigenetics, particularly its implications in sectors such as oncology, longevity, and drug development. She stated, "Epigenica enables fast, scalable, and affordable analysis of epigenetic biomarkers, thereby empowering researchers to tap into the full potential of multi-omics in the quest for innovative diagnostics and therapies."

Epigenica’s CEO, Mohamad Takwa, remarked on the technological advancements made since the company’s inception. He said, "We have refined our technology into an extensive range of products catering to diverse epigenetic applications. We envision various significant product launches within the year, which will empower our clients to enhance and broaden their research endeavors. I am excited to welcome Voima Ventures, Navigare Ventures, and Leksell Social Ventures and deeply appreciate the continual support and trust of our existing shareholders. This funding strongly endorses our scientific and commercial growth."

The funds raised will expedite the development and commercialization of Epigenica’s flagship offerings, such as the already available EpiFinder Genome and the impending EpiFinder Global and EpiFinder cNUC kits. Additionally, it will bolster the expansion of the company's service offerings and data infrastructure, paving the way for an entrance into the U.S. market.

About Epigenica

Epigenica is a prominent life sciences technology company that is revolutionizing high-throughput epigenetic solutions specifically tailored for research, diagnostics, and drug development. Utilizing the proprietary EpiFinder platform, Epigenica enables simultaneous analyses of various epigenetic markers across a multitude of samples with exceptional resolution and efficiency at an economical rate. The company boasts an extensive product portfolio designed to accommodate different applications across oncology, pharmaceutical development, and longevity.

Empowered by Epigenica's patented high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the platform provides scalable and cost-effective epigenomic profiling across assorted starting materials. Epigenica is dedicated to assisting customers in producing actionable insights that advance multi-omics and translational research, facilitate biomarker discovery, and accelerate next-generation sequencing applications aimed at enhancing human health.

Corporate Information

Mohamad Takwa, Ph.D., serves as the CEO of Epigenica. The company maintains a strong commitment to advancing science and innovation in the epigenetics space.

Frequently Asked Questions

What is the purpose of the $2.2 million investment?

The investment aims to accelerate the commercialization of Epigenica's flagship products, enhance their service offerings, and support their entry into the U.S. market.

Who are the key investors in this funding round?

Key investors include Voima Ventures, Navigare Ventures, Leksell Social Ventures, and Almi Invest.

What unique technology does Epigenica utilize?

Epigenica utilizes the EpiFinder platform for simultaneous analysis of multiple epigenetic markers across many samples, offering high resolution and efficiency.

How does epigenetics impact biological research?

Epigenetics plays a vital role in understanding how lifestyle and environmental factors influence gene expression, which has implications in areas such as oncology and drug development.

What future product launches are expected from Epigenica?

Epigenica anticipates launching new products, including the EpiFinder Global and EpiFinder cNUC kits, in the near future.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 86

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Five SEAL Medal of Honor Signatures, One Charity Lot

Updated Category News Views 74

A single rifle can carry a staggering amount of meaning when the names on it belong to all five living U.S. Navy SEAL Medal of Honor recipients. Rock Island Auction Company plans to offer that one-of-a-kind custom precision rifle during its December 4–6, 2026 Premier Firearms Auction, and the financial arrangement is unusually clean: 100% of proceeds are slated for the...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 64

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading
Point72 Breach Puts Cyber Controls Under the Microscope

Updated Category News Views 76

Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 79

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
Candel’s BLA Delay Puts Disclosure Timing Under Fire

Updated Category News Views 150

A December filing turned into a mid-2027 wait, and Candel shareholders absorbed the damage in one ugly trading session. On November 13, shares of Candel Therapeutics fell 26% after the company disclosed that its biologics license application, or BLA, for aglatimagene in prostate cancer was no longer expected in December 2026. The revised plan is to submit in the middle of...

Continue Reading
SQM Investigation Puts Chile Approval Claims on Trial

Updated Category News Views 42

A Regulatory Promise Meets a Rough Earnings Reaction A 5.52% haircut after disappointing quarterly numbers is the sort of thing that makes shareholders stop pretending every loose management comment is harmless. Sociedad Química y Minera de Chile, NYSE:SQM, is facing an investigation by Levi & Korsinsky into public statements concerning regulatory matters, particularly...

Continue Reading
Würk's Bryte AI Targets Payroll's Costly Friction Points

Updated Category News Views 104

Payroll mistakes are the sort of paper cuts that suddenly turn into a hospital bill for an employer. Würk’s Nov. 19 launch of Bryte AI goes straight at that ugly reality in cannabis, beverage alcohol, and other heavily regulated workplaces, where a bad time entry, missed document, or misunderstood policy can create a far more expensive mess than ordinary office...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 135

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 72

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading

Top 5 Most Recently Viewed Articles

India's AI Market: Open Source Fueling Massive Growth

Updated Category News Views 195

February 17, 2026, and the buzz is all about India’s AI landscape—open source is the name of the game. The Linux Foundation just dropped a hefty report claiming India’s AI market will skyrocket from $6 billion in 2024 to nearly $32 billion by 2031. Seriously, that’s some jaw-dropping growth fueled by a mix of homegrown talent, strong government support, and an...

Continue Reading
Growth Projections for the Expanding UV LED Market

Updated Category News Views 115

Understanding the UV LED Market Surge The UV LED market is witnessing a remarkable transformation, with projections indicating it will reach a valuation of USD 2.16 billion by 2030. This trend marks a substantial growth from its anticipated value of USD 1.23 billion in 2025, leading to a compound annual growth rate (CAGR) of 11.9%. Key Factors Driving Market Growth The...

Continue Reading
Microsoft Partners with Constellation to Restart Three Mile Island

Updated Category News Views 136

Revitalizing Three Mile Island with Innovative Solutions Constellation Energy has teamed up with Microsoft (NASDAQ: MSFT) in an exciting partnership aimed at restarting a unit of the Three Mile Island nuclear plant in Pennsylvania. This initiative marks the first attempt to revive a retired nuclear facility, showcasing the changing dynamics in energy solutions. As...

Continue Reading
Investigation of WideOpenWest, Inc. Over Potential Wrongdoing

Updated Category News Views 152

WideOpenWest, Inc. Under Investigation for Fiduciary Breaches The DJS Law Group has initiated an investigation on behalf of investors regarding WideOpenWest, Inc. (NYSE: WOW). This investigation is focused on potential breaches of fiduciary duty that may have occurred within the company's board of directors and management. The aim is to determine if the directors have...

Continue Reading
Guidehouse Earns Recognition as Celonis Partner of the Year

Updated Category News Views 266

Guidehouse Recognized as Celonis Public Sector Partner of the Year Innovation is at the forefront of modern public sector operations, and Guidehouse has made significant strides in this area. The firm was honored with the Celonis Public Sector Partner of the Year award, showcasing its dedication to transforming government processes through advanced technology. Leading...

Continue Reading